Nienke M. De Wit
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Distinct CSF lipidomic profiles are associated with five proteomic subtypes in patients with Alzheimer's disease.
Journal: Molecular neurodegeneration advances
Published: July 17, 2025
Endothelial-Ercc1 DNA repair deficiency provokes blood-brain barrier dysfunction.
Journal: Cell death & disease
Published: May 14, 2024
The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier.
Journal: European journal of cell biology
Published: December 01, 2023
Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier.
Journal: Fluids and barriers of the CNS
Published: August 08, 2023
Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2.
Journal: Cell death & disease
Published: July 04, 2023
Crossing borders in Alzheimer's disease: A T cell's perspective.
Journal: Advanced drug delivery reviews
Published: March 30, 2022
The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease.
Journal: Frontiers in immunology
Published: October 22, 2020
How can vulnerable groups be recruited to participate in a community-based smoking cessation program and perceptions of effective elements: A qualitative study among participants and professionals.
Journal: Tobacco prevention & cessation
Published: April 20, 2020
Profiling the unique protective properties of intracranial arterial endothelial cells.
Journal: Acta neuropathologica communications
Published: July 26, 2019
Sphingolipids in Alzheimer's disease, how can we target them?
Journal: Advanced drug delivery reviews
Published: June 19, 2019
Liver X Receptor Alpha Is Important in Maintaining Blood-Brain Barrier Function.
Journal: Frontiers in immunology
Published: February 06, 2019
Last Updated: 09/26/2026